|
|
The future of drug discovery and development: Shifting emphasis towards personalized medicine
Arsia Amir Aslani
,
Vincent Mangematin
Journal articles
istex
hal-00749148v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Do Science and Money Go Together? The Case of the French Biotech Industry
Rodolphe Durand
,
Olga Bruyaka
,
Vincent Mangematin
Journal articles
hal-00422650v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
When technological discontinuities and disruptive business models challenge dominant industry logics: insights from the drugs industry
Valérie Sabatier
,
Adrienne Kennard
,
Vincent Mangematin
Journal articles
hal-00658727v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Sharing research facilities : Towards a new mode of technology transfer ?
Ashveen Peerbaye
,
Vincent Mangematin
Innovation: Management, Policy and Practice, 2005, 7 (1), pp. 23-38
Journal articles
hal-00916371v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Which Model of Technology Transfer for Nanotechnology? A Comparison with Biotech and Microelectronics
Corine Genet
,
Khalid Errabi
,
Caroline Gauthier
Journal articles
hal-00749152v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Business model performance: five key drivers
Meyer Haggège
,
Caroline Gauthier
,
Charles-Clemens Rüling
Journal articles
hal-01592049v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|